What liver-related side effects have been reported with tigecycline?
Tigecycline can affect the liver. Reported liver-related adverse effects include elevations in liver enzymes (such as alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) and, in some cases, drug-induced liver injury patterns. These changes are part of the overall adverse event profile seen with tigecycline therapy [1].
How do clinicians monitor for liver toxicity?
Because tigecycline can raise liver enzymes, clinicians typically monitor liver function tests during treatment—especially in patients who already have liver disease or who are receiving other medications that can also affect the liver. If liver enzyme levels rise substantially or symptoms of liver injury appear (for example, jaundice, dark urine, or significant fatigue), clinicians may reassess ongoing tigecycline use and evaluate other causes [1].
Which patients may be at higher risk?
Risk is likely higher in people with:
- Pre-existing liver impairment or underlying chronic liver disease.
- Concurrent use of other drugs that can stress the liver.
- Serious illness, which can complicate interpretation of abnormal liver tests.
The key practical point is that tigecycline-associated enzyme elevations have been observed across treated patients, so higher-risk patients often need closer monitoring [1].
What should patients watch for?
Patients should seek medical advice promptly if they develop signs or symptoms that can suggest liver injury while on tigecycline, including jaundice (yellowing of the skin/eyes), dark urine, pale stools, severe itching, or right upper abdominal pain. These symptoms require prompt evaluation and liver test re-checking [1].
Is the liver risk dose- or duration-dependent?
The product safety information supports that liver enzyme abnormalities can occur during therapy, but it does not provide a simple rule like "risk increases linearly with dose." Clinically, risk can be influenced by patient factors (baseline liver status) and overall illness severity, so monitoring is usually emphasized rather than relying on dose-duration alone [1].
Bottom line
Yes. Tigecycline has known potential risks to liver function, including elevations in liver enzymes and possible drug-induced liver injury. Liver function testing and prompt evaluation of symptoms are the main safeguards [1].
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/